Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.87 HKD | -0.35% | +4.74% | -17.29% |
Apr. 30 | Wall Street, Earnings, Federal Reserve Roil Asian Stock Markets | MT |
Apr. 30 | Sino Biopharmaceutical Limited Announces Approval for Marketing of Category 1 Unecritinib Fumarate Capsules | CI |
Evolution of the average Target Price on Sino Biopharmaceutical Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sino Biopharmaceutical Limited
Nomura | |
UBS |
EPS Revisions
- Stock Market
- Equities
- 1177 Stock
- Consensus Sino Biopharmaceutical Limited